Vesedaganat: nyitott vizsgálatok itt: Kína
116 trials · From ClinicalTrials.gov, checked 2026. nov. 10.. Ask the study team whether a trial fits you.
2. fázisToborozTrial-stage medicine
A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
- Where
- Shanghai
- Age
- 18 év and over
- People
- 30
- Run by
- Imbioray (Hangzhou) Biomedicine Co., Ltd.
See details and how to joinNCT07087158Regiszter frissítve: 2026-11-05
2. fázisToborozTrial-stage medicine
Prospective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
- Where
- Beijing
- Age
- 18 év and over
- People
- 54
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07909265Regiszter frissítve: 2026-11-02
No phaseToborzás még nem indultResearch participation
Federated Learning in Renal Tumor Model
- Where
- Guigang, Guilin, Liuzhou, Nanning, Wuzhou
- Age
- 18 év to 60 év
- People
- 3000
- Run by
- First Affiliated Hospital of Guangxi Medical University
See details and how to joinNCT07841756Regiszter frissítve: 2026-10-30
No phaseToborzás még nem indultResearch participation
Habitat Analysis of Tumor Thrombus for Vena Cava Wall Invasion in Renal Cell Carcinoma
- Where
- Beijing
- Age
- 18 év and over
- People
- 273
- Run by
- Liu Zhuo
See details and how to joinNCT07901569Regiszter frissítve: 2026-10-28
1/2. fázisToborozTrial-stage medicine
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Beijing, Changsha Shi, Guangzhou, Harbin, Nanjing, Shanghai Shi, Tianjin
- Age
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351EU 2026-527163-15-00Regiszter frissítve: 2026-10-23
2. fázisToborozTrial-stage medicine
An Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
- Where
- Guangzhou, Zhengzhou
- Age
- 18 év and over
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT06730672Regiszter frissítve: 2026-10-22
No phaseToborozResearch participation
Effect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
- Where
- Nanjing
- Age
- 18 év to 75 év
- People
- 304
- Run by
- Shao Pengfei
See details and how to joinNCT07888608Regiszter frissítve: 2026-10-22
2. fázisToborzás még nem indultTrial-stage medicine
A Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
- Where
- Beijing
- Age
- 18 év and over
- People
- 100 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07877194Regiszter frissítve: 2026-10-16
2. fázisToborozTrial-stage medicine
Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
- Where
- Nanjing
- Age
- 18 év to 75 év
- People
- 162
- Run by
- Jinling Hospital, China
See details and how to joinNCT07672860Regiszter frissítve: 2026-10-15
No phaseToborozResearch participation
Plasma DNA Methylation for Preoperative Classification of Renal Masses
- Where
- Shanghai
- Age
- 18 év and over
- People
- 240
- Run by
- RenJi Hospital
See details and how to joinNCT07874542Regiszter frissítve: 2026-10-15
Korai 1. fázisToborzás még nem indultResearch participation
68Ga- and 18F-CAIX PET Imaging Study
- Where
- Beijing
- Age
- 18 év and over
- People
- 100
- Run by
- Peking University First Hospital
See details and how to joinNCT07875946Regiszter frissítve: 2026-10-15
No phaseToborozResearch participation
18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
- Where
- Beijing
- Age
- 18 év and over
- People
- 80
- Run by
- Peking University First Hospital
See details and how to joinNCT07875959Regiszter frissítve: 2026-10-15
1. fázisToborozTrial-stage medicine
Clinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)
- Where
- Beijing
- Age
- 18 év to 75 év
- People
- 15
- Run by
- Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT07770802Regiszter frissítve: 2026-10-14
No phaseToborozResearch participation
CAIX-targeted PET/CT in Solid Tumors
- Where
- Wuhan
- Age
- 18 év and over
- People
- 100
- Run by
- Zhongnan Hospital
See details and how to joinNCT07833085Regiszter frissítve: 2026-10-13
1/2. fázisToborozTrial-stage medicine
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Where
- Beijing, Changsha, Chongqing, Jinan, Nanjing, Ningbo, Wuhan
- Age
- 18 év and over
- People
- 224 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227415EU 2025-523524-53-00Regiszter frissítve: 2026-10-08
Korai 1. fázisToborzás még nem indultTrial-stage medicine
A Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma
- Where
- Beijing
- Age
- 18 év to 75 év
- People
- 6
- Run by
- Liangyou Gu
See details and how to joinNCT07865832Regiszter frissítve: 2026-10-08
2. fázisToborzás még nem indultTrial-stage medicine
SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
- Where
- Fuzhou
- Age
- 18 év to 80 év
- People
- 27
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07470840Regiszter frissítve: 2026-10-01
No phaseToborozResearch participation
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
- Where
- Beijing
- Age
- 18 év to 75 év
- People
- 120
- Run by
- Peking University First Hospital
See details and how to joinNCT07039474Regiszter frissítve: 2026-09-28
No phaseToborozTrial-stage medicine
QLESP Block for Pain Control in Robotic Partial Nephrectomy
- Where
- Wuhan
- Age
- 18 év to 80 év
- People
- 120
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07704970Regiszter frissítve: 2026-09-25
No phaseToborozResearch participation
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
- Where
- Qingdao
- Age
- 18 év to 75 év
- People
- 120
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT06916624Regiszter frissítve: 2026-09-17
1. fázisToborozTrial-stage medicine
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Jinan
- Age
- 18 év to 75 év
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369Regiszter frissítve: 2026-08-21
1. fázisToborozTrial-stage medicine
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- Where
- Beijing, Changsha, Guangzhou, Jinan, Jining, Shanghai, Shenyang, Shijiazhuang
- Age
- 18 év and over
- People
- 738 worldwide
- Run by
- NextCure, Inc.
See details and how to joinNCT06792552Regiszter frissítve: 2026-08-17
1/2. fázisToborozTrial-stage medicine
Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
- Where
- Beijing
- Age
- 18 év to 75 év
- People
- 92
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07239596Regiszter frissítve: 2026-08-11
2. fázisToborozTrial-stage medicine
CD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
- Where
- Nanjing, Wuxi
- Age
- 18 év and over
- People
- 75
- Run by
- Jinling Hospital, China
See details and how to joinNCT07615348Regiszter frissítve: 2026-08-11
No phaseToborozResearch participation
An MRI-Based Study of Intelligent Pathological Subtyping and Grading of Renal Tumors
- Where
- Beijing
- Age
- 18 év and over
- People
- 900
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07743749Regiszter frissítve: 2026-08-04
Minden vizsgálat (Vesedaganat) és a térkép
Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.